Annual Report

Phathom Pharmaceuticals, Inc. Filed 2021-03-30 Acc 0001564590-21-016682

Documents 1

2022-03-01 10-K Annual Report
2021-04-05 4 Chief Operating Officer sold 14,500 shares at an average $36.63 ($531,102)
2021-04-01 SC 13D/A Beneficial Ownership Report
2021-03-30 10-K Annual Report
2021-03-30 8-K Results of operations
2021-03-23 4 President and Chief Executive sold 11,513 shares at an average $43.32 ($498,751)
2020-03-19 10-K Annual Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading phat-10k_20201231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…